Evidence overview
Vitamin B12
Vitamin B12 is essential and not produced by humans, so adequate intake is required. The supplementation literature divides cleanly into two populations: people at risk of deficiency (vegans and vegetarians, older adults, people on certain medications), where the evidence and clinical consensus for supplementation are clear and strong; and people with adequate intake, where supplementation has limited additional benefit. Most modern research focuses on the at-risk populations.
Most studied for
Coverage pending
PubMed coverage
Coverage pending
Safety profile
In your full report
Mechanism class
Water-soluble essential vitamin required for DNA synthesis, red blood cell formation, neurological function, and...
Study coverage
Study coverage by goal
PubMed counts for Vitamin B12 grouped by the goal each study targets.
Evidence overview is temporarily unavailable for Vitamin B12.
Evidence
What the evidence covers
The terrain of the published literature, not its conclusions.
Vitamin B12 is one of the longest-studied essential nutrients and the supplementation literature divides clearly between at-risk populations (where the evidence is strong and consensus is clear) and the general population (where evidence for additional benefit is limited). B12 is produced by bacteria and naturally present in animal-source foods - meat, fish, eggs, dairy - which is why plant-based dietary patterns are the principal at-risk population in modern trials. The body absorbs B12 through a specific intrinsic-factor-mediated pathway in the small intestine; this absorption capacity declines with age, gastric surgery, and certain long-term medications (metformin, proton pump inhibitors, H2 blockers).
The outcome dimensions covered most heavily are vitamin B12 status in vegan and vegetarian populations (the dominant modern research wave), classical pernicious anemia treatment (the historically foundational use, now mostly managed in primary care), neurological symptoms of deficiency (peripheral neuropathy, cognitive symptoms in older adults), pregnancy and infant nutrition, and homocysteine lowering. High-dose oral supplementation vs. intramuscular injection is an active research question; modern evidence supports high-dose oral as effective for most cases, including in classical pernicious anemia, which has shifted clinical practice over the past two decades.
Demographically, the literature concentrates on three populations: vegans and vegetarians (the modern research focus), older adults (cognitive and absorption-decline research), and pregnant women (fetal neural development context). Methylcobalamin vs. cyanocobalamin form preference is a common consumer-marketing distinction; head-to-head trials are thinner than the marketing implies, and current evidence does not consistently favor one form over the other for most users.
Safety
Safety summary
Common adverse events, drug interactions, and special populations.
Vitamin B12 has an unusually clean safety profile. The IOM has not established a tolerable upper limit because adverse effects from high oral intake have not been documented; excess B12 is excreted in urine. The most-common adverse events in trials are mild gastrointestinal discomfort and headache at low frequencies. Drug interactions are limited; metformin, proton pump inhibitors, and H2 blockers can reduce B12 absorption, which is why long-term users of these medications are sometimes screened for B12 status. Injectable B12 (a clinical-setting route, not consumer supplementation) has rare reported adverse events including allergic reactions; these are not relevant to oral supplementation. People with Leber's hereditary optic neuropathy have an established concern with cyanocobalamin specifically and should use methylcobalamin or hydroxocobalamin under clinician guidance.
This summary is informational and not medical advice. Consult a clinician before starting or changing any supplement, especially if you take prescription medications.
Foundations
Foundation of the evidence base
A few studies the field anchors on. Not the full picture, just the starting points.
Position paper from the Italian Society of Human Nutrition providing the consensus framework for B12 supplementation in vegetarian dietary patterns - the population at highest modern risk and the most-asked consumer context for B12.
View on PubMedConsensus statement from the European pediatric gastroenterology and nutrition society establishing recommendations for B12 in vegan children and adolescents. The clearest practice-guideline reference for pediatric vegan B12 supplementation.
View on PubMedRecent meta-analysis quantifying functional B12 status in unsupplemented adult vegans, providing the empirical foundation that supports the strong supplementation recommendations from the pediatric and adult nutrition guideline bodies.
View on PubMed
Limitations
What this page doesn't answer
Where the public summary stops and the personalized report begins.
This page summarizes the B12 literature at a general level. It does not address whether your specific dietary pattern puts you at risk, what dose or form is right for your situation, how your absorption capacity (which varies with age, gastric health, and medications) affects your needs, or whether you have a true functional deficiency (which requires lab testing of serum B12 and methylmalonic acid). Whether you benefit from supplementation depends almost entirely on whether your diet and absorption provide enough B12, which is exactly the kind of question the personalized report can address with your specific context.
Personalized to you
Get a personalized Vitamin B12 report
Your free first report adds the things this page doesn't: per-goal evidence breakdown, demographic-specific findings, full citation list, and a safety section tailored to your profile.
Free first report. No credit card. Cancel anytime.
Get notified when new evidence appears
We'll email you when the literature on Vitamin B12 materially updates. No account required.